Product Information
PITAVASTATIN 2 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.9865 per EA under NDC 00378505677. Its NADAC has been published 136 times since Jan 17, 2024.
FDA first approved this application on Apr 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378505677
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206070FDA Approved
4/4/2019
TE Code
AB
On Market Since
11/2/2023
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 2 MG TABLET has been published 136 times since Jan 17, 2024, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9865 per EA |
|---|---|
| All-time high | $2.4472 (Apr 10, 2024) |
| All-time low | $0.9865 (Aug 19, 2026) |
| 52-week high | $1.4992 |
| 52-week low | $0.9865 |
| Median price | $1.4814 |
| Average price | $1.5464 |
| Largest weekly change | -32.5% (Nov 20, 2024) |
| Weeks tracked | 136 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pitavastatin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PITAVASTATIN 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 2 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.9865 per EA (NDC 00378505677), effective Aug 19, 2026.
How has the price of PITAVASTATIN 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 2 MG TABLET has declined 51.8%. It has been tracked across 136 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 2 MG TABLET?
Since Jan 17, 2024, the NADAC for PITAVASTATIN 2 MG TABLET has ranged from a low of $0.9865 (Aug 19, 2026) to a high of $2.4472 (Apr 10, 2024), with a median of $1.4814 per EA.
Are there cheaper alternatives to PITAVASTATIN 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PITAVASTATIN 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PITAVASTATIN 2 MG TABLET?
PITAVASTATIN 2 MG TABLET (NDC 00378505677) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.